Meridian Wealth Management, LLC Invitae Corp Transaction History

Meridian Wealth Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$1.2 - $2.73 $13,380 - $30,439	11,150 New	11,150 $15,000
Q4 2021 Jan 27, 2022	SELL	$14.7 - $28.67 $127,404 - $248,482	-8,667 Closed	0 $0
Q3 2021 Oct 15, 2021	BUY	$24.31 - $33.6 $24,310 - $33,600	1,000 Added 13.04%	8,667 $246,000
Q2 2021 Jul 22, 2021	BUY	$26.09 - $40.4 $1,695 - $2,626	65 Added 0.86%	7,667 $259,000
Q1 2021 May 07, 2021	BUY	$33.06 - $56.93 $58,383 - $100,538	1,766 Added 30.26%	7,602 $290,000
Q4 2020 Jan 19, 2021	BUY	$39.09 - $57.4 $228,129 - $334,986	5,836 New	5,836 $244,000

2.12M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Meridian Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Meridian Wealth Management, LLC with notifications on news.